US68218J1034
© BusinessWire
15.12.2025
OABI
LISTED
NASDAQ
Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies
News Preview
OmniAb, Inc. (NASDAQ: OABI) announces the launch of its new OmniUltra™ platform, the industry’s first and only transgenic chicken engineered to express ultralong CDRH3 domains on a human antibody framework, at the 2025 Antibody Engineering & Therapeutics (AET) Conference underway in San Diego.
This press release features multimedia. View the f...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
OABI
LISTED
NASDAQ
OmniAb to Hold OmniUltra Virtual Investor Event on December 15
News Preview
OmniAb, Inc. (NASDAQ: OABI) today announced it will hold a virtual investor event to showcase the launch of OmniUltra™ on Monday, December 15, 2025, beginning at 5:00 p.m. Eastern time.
The event is expected to last approximately one hour and will include a review of OmniAb’s newest technology offering, OmniUltra, the industry's only transgenic c...
Themefolio
Profiler
Peergroup
© BusinessWire
17.11.2025
OABI
LISTED
NASDAQ
OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors
News Preview
OmniAb, Inc. (NASDAQ: OABI) and ArrowMark Partners (“ArrowMark”) today announced the signing of a license and services agreement for novel OmniAb-derived antibody discovery programs with Mabtrx Biosciences, a wholly owned subsidiary of AMVKG LS, a joint venture (JV) between ArrowMark and Viking Global Investors (“Viking”).
Under the terms of the...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
04.11.2025
OABI
LISTED
NASDAQ
OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights
News Preview
OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and nine months ended September 30, 2025, and provided operating and partner program updates.
“Throughout the third quarter we continued to execute on our strategic initiatives while further demonstrating the value of our proprietary technology platform to a growing base o...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
16.10.2025
OABI
LISTED
NASDAQ
OmniAb to Participate in Three Investor Conferences in November
News Preview
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in three investor conferences during the month of November.
2025 Truist Securities BioPharma Symposium, November 6 at the Lotte New York Palace Hotel. Matt Foehr, Chief Executive Officer, will participate in one-on-one meetings with investors on Thursday, November...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
OABI
LISTED
NASDAQ
OmniAb to Report Third Quarter 2025 Financial Results on November 4
News Preview
OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and nine months ended September 30, 2025, after the close of the U.S. financial markets on Tuesday, November 4, 2025, and will hold a conference call that same day beginning at 4:30 p.m. Eastern time.
Conference Call and Webcast Information
What:
OmniAb con...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
OABI
LISTED
NASDAQ
OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
OmniAb, Inc. (NASDAQ: OABI) today announced that management will participate at the H.C. Wainwright 27th Annual Global Investment Conference taking place September 8-10, 2025 at the Lotte New York Palace Hotel. Management will be available for one-on-one meetings on Tuesday, September 9th with investors registered for the event.
Investors intere...
Themefolio
Profiler
Peergroup
© BusinessWire
25.08.2025
OABI
LISTED
NASDAQ
OmniAb Announces $30 Million Private Placement
News Preview
OmniAb, Inc. (NASDAQ: OABI) today announced it has entered into a definitive securities purchase agreement to issue and sell an aggregate of 21,254,106 shares of its common stock at a price of $1.40 per share (or $1.85 per share for officer and director participation), in a private placement. OmniAb anticipates the gross proceeds from the private...
Themefolio
Profiler
Peergroup
© BusinessWire
16.07.2025
OABI
LISTED
NASDAQ
OmniAb to Report Second Quarter 2025 Financial Results on August 6
News Preview
OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on Wednesday, August 6, 2025, and will hold a conference call that same day beginning at 4:30 p.m. Eastern time.
Conference Call and Webcast Information
What:
OmniAb conference call to...
Themefolio
Profiler
Peergroup
© PR Newswire
30.06.2025
OABI
LISTED
NASDAQ
AI Is Quietly Reinventing Healthcare--And Real Deployments Are Now Underway
News Preview
Equity Insider News Commentary
Issued on behalf of Avant Technologies Inc.
VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- Several experts are seeing that value of AI's total overhaul of healthcare, including beneficial additions such as generative AI apps demonstrating real value. The next wave of AI's healthcare transformation is already taking sh...
Themefolio
Profiler
Peergroup
© PR Newswire
30.06.2025
OABI
LISTED
NASDAQ
AI Is Quietly Reinventing Healthcare--And Real Deployments Are Now Underway
News Preview
Equity Insider News Commentary
Issued on behalf of Avant Technologies Inc.
VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- Several experts are seeing that value of AI's total overhaul of healthcare, including beneficial additions such as generative AI apps demonstrating real value. The next wave of AI's healthcare transformation is already taking sh...
Themefolio
Profiler
Peergroup
© PR Newswire
30.06.2025
OABI
LISTED
NASDAQ
AI Is Quietly Reinventing Healthcare--And Real Deployments Are Now Underway
News Preview
Equity Insider News Commentary
Issued on behalf of Avant Technologies Inc.
VANCOUVER, BC, June 30, 2025 /CNW/ -- Several experts are seeing that value of AI's total overhaul of healthcare, including beneficial additions such as generative AI apps demonstrating real value. The next wave of AI's healthcare transformation is already taking shape—led...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
13.05.2025
OABI
LISTED
NASDAQ
OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit
News Preview
OmniAb, Inc. (NASDAQ: OABI) today announced its participation in the 21st Annual PEGS Boston – The Essential Protein & Antibody Engineering Summit underway at the Omni Hotel. Earlier today, the company showcased case studies utilizing xPloration, a high-throughput single B-cell screening platform that harnesses machine learning and computer vi...
Themefolio
Profiler
Peergroup
© BusinessWire
08.05.2025
OABI
LISTED
NASDAQ
OmniAb Reports First Quarter 2025 Financial Results and Business Highlights
News Preview
OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three months ended March 31, 2025, and provided operating and partner program updates.
“We have started the year with robust deal flow, including both platform and asset-based deals. Our business remains strong as our diversified pipeline of partner programs is progressing with...
Themefolio
Profiler
Peergroup
© BusinessWire
08.05.2025
OABI
LISTED
NASDAQ
OmniAb Introduces the xPloration® Partner Access Program
News Preview
OmniAb, Inc. (NASDAQ: OABI) today introduced the launch of the xPloration Partner Access Program, under which current OmniAb partners can purchase the xPloration instrument to significantly enhance their capabilities in antibody discovery and development. xPloration is OmniAb’s proprietary, innovative, high-throughput single B-cell screening platf...
Themefolio
Profiler
Peergroup
© BusinessWire
01.05.2025
OABI
LISTED
NASDAQ
OmniAb to Participate in Five Upcoming Investor Conferences
News Preview
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in five investor conferences over the coming weeks.
H.C. Wainwright 1st Annual Royalty Company Virtual Conference, May 13. Management will participate in a fireside chat and a panel discussion on Tuesday, May 13th.
H.C. Wainwright 3rd Annual BioConnect Investor...
Themefolio
Profiler
Peergroup
© BusinessWire
21.04.2025
OABI
LISTED
NASDAQ
OmniAb Announces Two New Appointments to its Board of Directors
News Preview
OmniAb, Inc. (NASDAQ: OABI) today announced the appointments of Philip J. Gotwals, Ph.D., and Steve Crouse to its Board of Directors. OmniAb also announced the departure of Director Sarah Boyce, who is stepping down following nearly six years of service during a period of key strategic acquisitions and the significant expansion of the scope and si...
Themefolio
Profiler
Peergroup
© BusinessWire
14.04.2025
OABI
LISTED
NASDAQ
OmniAb to Report First Quarter 2025 Financial Results on May 8
News Preview
OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on Thursday, May 8, 2025, and will hold a conference call that same day beginning at 4:30 p.m. Eastern time.
Conference Call and Webcast Information
What:
OmniAb conference call to discuss fi...
Themefolio
Profiler
Peergroup
© BusinessWire
18.03.2025
OABI
LISTED
NASDAQ
OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
News Preview
OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and 12 months ended December 31, 2024, and provided operating and partner program updates.
“2024 was a remarkable year featuring double-digit percentage growth in the number of both active partners and programs. Clinical-stage programs advanced well, and we launched new te...
Themefolio
Profiler
Peergroup
© BusinessWire
24.02.2025
OABI
LISTED
NASDAQ
OmniAb to Report Fourth Quarter 2024 Financial Results on March 18
News Preview
OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and 12 months ended December 31, 2024 after the close of the U.S. financial markets on Tuesday, March 18, 2025 and will hold a conference call that same day beginning at 4:30 p.m. Eastern time.
Conference Call and Webcast Information
What:
OmniAb conference call to...
Themefolio
Profiler
Peergroup
© BusinessWire
03.02.2025
OABI
LISTED
NASDAQ
OmniAb to Participate in Two Investor Conferences in March
News Preview
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in two investor conferences during the month of March.
TD Cowen 45th Annual Health Care Conference, March 3-5 at the Boston Marriott Copley Place. Management will be presenting a corporate overview on Tuesday, March 4th at 2:30 p.m. Eastern time and will be holdin...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2024
OABI
LISTED
NASDAQ
OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference
News Preview
OmniAb, Inc. (NASDAQ: OABI) today announced that two presentations featuring the Company’s technologies were delivered at the 2024 Antibody Engineering & Therapeutics Conference (AETC) underway in San Diego.
In a presentation titled “Building Multispecifics from in vivo Derived Antibody Domains and Alternative Scaffolds,” Yasmina Abdiche, Ph...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2024
OABI
LISTED
NASDAQ
OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights
News Preview
OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and nine months ended September 30, 2024, and provided operating and partner program updates.
“We are pleased to report another successful quarter demonstrating our continued commitment to innovation with the expansion of our technology platform and a growing partnership...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2024
OABI
LISTED
NASDAQ
OmniAb to Participate in Two Investor Conferences in November
News Preview
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in two investor conferences during the month of November.
Stifel 2024 Healthcare Conference, November 18-19 at the Lotte New York Palace Hotel. Kurt Gustafson, Chief Financial Officer, will participate in one-on-one meetings with investors on Tuesday, November 19th...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2024
OABI
LISTED
NASDAQ
OmniAb to Report Third Quarter 2024 Financial Results on November 12
News Preview
OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and nine months ended September 30, 2024 after the close of the U.S. financial markets on Tuesday, November 12, 2024 and will hold a conference call that same day beginning at 4:30 p.m. Eastern time.
Conference Call and Webcast Information
What:
OmniAb conference c...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2024
OABI
LISTED
NASDAQ
OmniAb to Participate in Two Investor Conferences in September
News Preview
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in two investor conferences during the month of September.
H.C. Wainwright 26th Annual Global Investment Conference, September 9-11 at the Lotte New York Palace Hotel. Management will deliver a corporate presentation on Tuesday, September 10th at 2:30 p.m. Eastern...
Themefolio
Profiler
Peergroup
© BusinessWire
08.08.2024
OABI
LISTED
NASDAQ
OmniAb Reports Second Quarter 2024 Financial Results and Business Highlights
News Preview
OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and six months ended June 30, 2024, and provided operating and partner program updates.
“Second quarter results were in-line with our expectations and support our view of the full year. We advanced our business by adding new partnerships and programs as existing partners...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
